We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

New In Vivo Electroporation System
Product News

New In Vivo Electroporation System

New In Vivo Electroporation System
Product News

New In Vivo Electroporation System

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New In Vivo Electroporation System"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The New AgilePulse® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications.

Patented Pulse Agile™ waveforms consists of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues.

Gene expression in skin is 100-fold higher when delivery is enhanced by electroporation compared to injection alone.

• Patented Pulse Agile® technology
• Resistance measurement for proper needle placement and reproducibility
• Specially designed needle arrays for intra-muscular or intra-dermal applications

• Enhanced immune response
• Increased Ag-specific T-cell response
• Gene expression is 100-fold higher